GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (NAS:PRQR) » Definitions » Institutional Ownership

ProQR Therapeutics NV (ProQR Therapeutics NV) Institutional Ownership : 2.29% (As of May. 23, 2024)


View and export this data going back to 2014. Start your Free Trial

What is ProQR Therapeutics NV Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ProQR Therapeutics NV's institutional ownership is 2.29%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ProQR Therapeutics NV's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ProQR Therapeutics NV's Float Percentage Of Total Shares Outstanding is 71.20%.


ProQR Therapeutics NV Institutional Ownership Historical Data

The historical data trend for ProQR Therapeutics NV's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProQR Therapeutics NV Institutional Ownership Chart

ProQR Therapeutics NV Historical Data

The historical data trend for ProQR Therapeutics NV can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 1.92 1.92 1.91 1.91 1.93 1.90 1.90 1.90 2.29 2.29

ProQR Therapeutics NV Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


ProQR Therapeutics NV (ProQR Therapeutics NV) Business Description

Traded in Other Exchanges
Address
Zernikedreef 9, Leiden, ZH, NLD, 2333 CK
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.